August 11, 2026 01:40 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jharkhand student protest turns tense: Water cannons, lathicharge after Assembly march barricades breached | ‘Mother tongue is as pure as one's mother’: Vijay-led Tamil Nadu government makes Tamil Thaai Vazhthu mandatory in big language push | Indian envoy Kwatra cites US, UK laws to counter ‘myths’ around FCRA Bill | Jharkhand students march to assembly today: JPSC row escalates despite govt action | ‘A morning I will cherish’: Raghav Chadha meets PM Modi, shares photos from ‘enriching’ meeting | Delhi Mercedes crash kills 70-year-old woman: Cop’s son behind wheel, beer bottle found | Indian-origin woman accused of ‘visa fraud’ on X: US Attorney steps in with major clarification | US Senate passes Russia sanctions bill: India can face Trump’s 100% tariff threat | Expired meat, rotten vegetables found at Bengaluru's luxury hotels, legal action begins | 'I'm ready to be humiliated': Vijay, Udhayanidhi Stalin clash in Tamil Nadu Assembly over Cauvery dispute
COVID19 Vaccine

US to possibly supply COVID-19 vaccine to other countries: Prez Donald Trump

| @indiablooms | Jul 29, 2020, at 05:52 pm

Washington/UNI:  US President Donald Trump during a press briefing said the United States may provide a vaccine for the novel coronavirus to other countries when it is ready.

"When we have that vaccine it will be discharged and taken care of," Trump told reporters on Tuesday. "It will be a very rapid process all over the country and perhaps we'll be supplying a lot of the vaccine to other parts of the world like we do with ventilators and other things that we all of a sudden have become very good at making."

The Trump administration aims to have a vaccine available by the end of the year or early 2021, says a Sputnik news report.

On Monday, the National Institutes of Health (NIH) said that US scientists have begun the phase three trial of the potential vaccine developed by the biotechnology company Moderna.

The NIH plans to conduct the trial at multiple US clinical research sites with participation of approximately 30,000 adult volunteers who are not infected with the novel coronavirus.

The United States has reported more than 4.3 million cases and more than 149,000 virus-related deaths as of Tuesday afternoon, according to data compiled by the Johns Hopkins University. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.